Dulaglutide treatment results in effective glycemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4, and -5 trials
Diabetes, Obesity and Metabolism Jan 31, 2018
Pozzilli P, et al. - Researchers planned this study to assess the effect of dulaglutide on glycemic control (HbA1c) in glutamic acid decarboxylase antibodies (GADA)-positive latent autoimmune diabetes of the adult (LADA) vs GADA-negative type-2-diabetes (T2D) patients. In LADA patients, dulaglutide was found to be effective at reducing HbA1c. Therefore, this drug aided in effective glycemic control in this study group.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
